Bayer’s 2nd-quarter profit down 1.3 percent
Germany’s Bayer AG saw second-quarter net earnings slip by 1.3 percent as a stronger revenue was offset by one-time charges for lawsuits and writing down a cancer drug.
Read more on KSWO Lawton-Wichita Falls
Eli Lilly’s profit jumps 16 percent
INDIANAPOLIS – Eli Lilly and Co. said Thursday its second-quarter net income soared 16 percent, boosted in part by revenue growth from key drugs that face patent expirations in the coming years.
Read more on Journal & Courier
Hope Against Hepatitis C
The late-trial success of telaprevir has given medical experts reason to believe a new wave of drugs could lead to far better treatment outcomes for patients who have the virus.
Read more on The Hendersonville Times-News
Eli Lilly 2Q profit jumps 16 pct on top drug sales
INDIANAPOLIS (AP) – Eli Lilly and Co. said Thursday its second-quarter net income soared 16 percent, boosted in part by revenue growth from key drugs that face patent expirations in the coming years.
Read more on Ventura County Star